Clinical Trial

TCM as an Adjuvant Treatment in Breast Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Summary
Chinese herbs can alleviates the side effects caused by conventional treatment in breast cancer patients and affects the syndrome element differentiation by altering the specific set of proteomes at specific time point of treatment.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-04-09; most recent amendment 2024-12-30.
Status change: Not Yet Recruiting → Recruiting 2022-11-02
Trial Details
NCT Number NCT04843865
Lead Sponsor Universiti Tunku Abdul Rahman
Conditions Breast Cancer, Musculoskeletal Pain
Enrollment 30 participants
Start Date 2022-04-22
Primary Completion 2024-12 (estimated)
Study Completion 2024-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-31